JavaScript is disabled in your browser. Please enable JavaScript to view this website.
AB34376

Anti-beta Amyloid 37-42 antibody - BSA and Azide free

Be the first to review this product! Submit a review

|

(14 Publications)

Rabbit Polyclonal Amyloid-beta precursor protein antibody. Carrier free. Suitable for ELISA and reacts with Synthetic peptide - Human samples. Cited in 14 publications.

View Alternative Names

A4, AD1, APP, Amyloid-beta precursor protein, ABPP, APPI, Alzheimer disease amyloid A4 protein homolog, Alzheimer disease amyloid protein, Amyloid precursor protein, Amyloid-beta (A4) precursor protein, Amyloid-beta A4 protein, Cerebral vascular amyloid peptide, PreA4, Protease nexin-II, CVAP, PN-II

1 Images
ELISA - Anti-beta Amyloid 37-42 antibody - BSA and Azide free (AB34376)
  • ELISA

Supplier Data

ELISA - Anti-beta Amyloid 37-42 antibody - BSA and Azide free (AB34376)

ELISA using ab34376 at varying antibody concentrations and antigen concentration at 1000 ng/mL.

Key facts

Host species

Rabbit

Clonality

Polyclonal

Isotype

IgG

Carrier free

Yes

Reacts with

Human

Applications

ELISA

applications

Reactivity data

{ "title": "Reactivity Data", "filters": { "stats": ["", "Species", "Dilution Info", "Notes"], "tabs": { "all-applications": {"fullname" : "All Applications", "shortname": "All Applications"}, "ELISA" : {"fullname" : "ELISA", "shortname":"ELISA"} }, "product-promise": { "all": "all", "testedAndGuaranteed": "tested", "guaranteed": "expected", "predicted": "predicted", "notRecommended": "not-recommended" } }, "values": { "Human": { "ELISA-species-checked": "predicted", "ELISA-species-dilution-info": "", "ELISA-species-notes": "" }, "Synthetic peptide - Human": { "ELISA-species-checked": "testedAndGuaranteed", "ELISA-species-dilution-info": "", "ELISA-species-notes": "<p></p>" } } }

Properties and storage information

Form
Liquid
Purification technique
Affinity purification Immunogen
Storage buffer
Constituents: PBS
Shipped at conditions
Blue Ice
Appropriate short-term storage duration
1-2 weeks
Appropriate short-term storage conditions
+4°C
Appropriate long-term storage conditions
-20°C
Aliquoting information
Upon delivery aliquot

Supplementary information

This supplementary information is collated from multiple sources and compiled automatically.

Beta Amyloid 37-42 a notable fragment of the amyloid precursor protein (APP) plays a role in protein aggregation. Alternative names include Aβ37-42 or amyloid-β (Aβ) peptide. This peptide segment has a known mass of approximately 4330 Da. Beta Amyloid 37-42 is mainly expressed in the brain particularly in neuronal tissues where its accumulation can affect cell function.
Biological function summary

The Beta Amyloid 37-42 fragment contributes to plaque formation found in the brains of affected individuals. This peptide can become part of a complex aggregating into oligomers and fibrils. These structures are important due to their impact on neural tissue and are studied extensively for their neurotoxic potential and involvement in synaptic dysfunction.

Pathways

Scientists have linked Beta Amyloid 37-42 activity to pathways involving proteolysis and amyloidogenic processing. It is heavily involved in the amyloid cascade pathway a series of events leading to peptide aggregation. Its interactions with other proteins such as presenilins in the γ-secretase complex are critical. These related proteins modulate β-secretase activity consequently influencing peptide production and accumulation.

Beta Amyloid 37-42 connections to Alzheimer's disease and cerebral amyloid angiopathy are evident. The buildup of this peptide is a hallmark of Alzheimer's pathology leading to cognitive decline. Additionally β-amyloid's relationship with tau proteins which form neurofibrillary tangles exacerbates neuronal damage highlighting its contribution to these neurodegenerative conditions.

Product protocols

For this product, it's our understanding that no specific protocols are required. You can visit:

Target data

Functions as a cell surface receptor and performs physiological functions on the surface of neurons relevant to neurite growth, neuronal adhesion and axonogenesis. Interaction between APP molecules on neighboring cells promotes synaptogenesis (PubMed : 25122912). Involved in cell mobility and transcription regulation through protein-protein interactions. Can promote transcription activation through binding to APBB1-KAT5 and inhibits Notch signaling through interaction with Numb. Couples to apoptosis-inducing pathways such as those mediated by G(o) and JIP. Inhibits G(o) alpha ATPase activity (By similarity). Acts as a kinesin I membrane receptor, mediating the axonal transport of beta-secretase and presenilin 1 (By similarity). By acting as a kinesin I membrane receptor, plays a role in axonal anterograde transport of cargo towards synapses in axons (PubMed : 17062754, PubMed : 23011729). Involved in copper homeostasis/oxidative stress through copper ion reduction. In vitro, copper-metallated APP induces neuronal death directly or is potentiated through Cu(2+)-mediated low-density lipoprotein oxidation. Can regulate neurite outgrowth through binding to components of the extracellular matrix such as heparin and collagen I and IV. The splice isoforms that contain the BPTI domain possess protease inhibitor activity. Induces a AGER-dependent pathway that involves activation of p38 MAPK, resulting in internalization of amyloid-beta peptide and leading to mitochondrial dysfunction in cultured cortical neurons. Provides Cu(2+) ions for GPC1 which are required for release of nitric oxide (NO) and subsequent degradation of the heparan sulfate chains on GPC1.. Amyloid-beta peptides are lipophilic metal chelators with metal-reducing activity. Bind transient metals such as copper, zinc and iron. In vitro, can reduce Cu(2+) and Fe(3+) to Cu(+) and Fe(2+), respectively. Amyloid-beta protein 42 is a more effective reductant than amyloid-beta protein 40. Amyloid-beta peptides bind to lipoproteins and apolipoproteins E and J in the CSF and to HDL particles in plasma, inhibiting metal-catalyzed oxidation of lipoproteins. APP42-beta may activate mononuclear phagocytes in the brain and elicit inflammatory responses. Promotes both tau aggregation and TPK II-mediated phosphorylation. Interaction with overexpressed HADH2 leads to oxidative stress and neurotoxicity. Also binds GPC1 in lipid rafts.. Appicans elicit adhesion of neural cells to the extracellular matrix and may regulate neurite outgrowth in the brain.. The gamma-CTF peptides as well as the caspase-cleaved peptides, including C31, are potent enhancers of neuronal apoptosis.
See full target information APP

Publications (14)

Recent publications for all applications. Explore the full list and refine your search

International journal of medical sciences 22:1736-1749 PubMed40225859

2025

Indoxyl sulfate is associated with cognitive impairment in ESRD patients by activating the extrinsic apoptosis in the neuronal cells during differentiating process.

Applications

Unspecified application

Species

Unspecified reactive species

Chih-Chuan Hsieh,Kuo-Cheng Lu,Chuen-Lin Huang,Jiun-Jie Wang,Ting-Yin Yeh,Shyh-Min Lin,Ya-Ling Chung,Yi-Chou Hou,Yuahn-Sieh Huang

ACS omega 10:7256-7263 PubMed40028141

2025

Ultrasensitive Assays Detect Different Conformations of Plasma β Amyloids.

Applications

Unspecified application

Species

Unspecified reactive species

Chia-Yu Li,Ling-Yun Fan,Chin-Hsien Lin,Chaur-Jong Hu,Ming-Jang Chiu

Clinical kidney journal 18:sfae283 PubMed39781476

2025

Cerebral white matter damage in patients with end-stage kidney disease associates with cognitive impairment.

Applications

Unspecified application

Species

Unspecified reactive species

Yi-Chou Hou,Chih-Chien Tsai,Ruei-Ming Chen,Yi-Chien Liu,Kuo-Cheng Lu,Yao-Liang Chen,Ting-Wen Shen,Jiun-Jie Wang

Alzheimer's & dementia (Amsterdam, Netherlands) 13:e12242 PubMed34692980

2021

The global Alzheimer's Association round robin study on plasma amyloid β methods.

Applications

Unspecified application

Species

Unspecified reactive species

Josef Pannee,Leslie M Shaw,Magdalena Korecka,Teresa Waligorska,Charlotte E Teunissen,Erik Stoops,Hugo M J Vanderstichele,Kimberley Mauroo,Inge M W Verberk,Ashvini Keshavan,Pedro Pesini,Leticia Sarasa,Maria Pascual-Lucas,Noelia Fandos,José-Antonio Allué,Erik Portelius,Ulf Andreasson,Ritsuko Yoda,Akinori Nakamura,Naoki Kaneko,Shieh-Yueh Yang,Huei-Chun Liu,Stefan Palme,Tobias Bittner,Kwasi G Mawuenyega,Vitaliy Ovod,James Bollinger,Randall J Bateman,Yan Li,Jeffrey L Dage,Erik Stomrud,Oskar Hansson,Jonathan M Schott,Kaj Blennow,Henrik Zetterberg

Frontiers in neurology 12:619388 PubMed34671305

2021

Prediction of Cerebral Amyloid Pathology Based on Plasma Amyloid and Tau Related Markers.

Applications

Unspecified application

Species

Unspecified reactive species

Ting-Bin Chen,Kun-Ju Lin,Szu-Ying Lin,Yi-Jung Lee,Yi-Cheng Lin,Chen-Yu Wang,Jun-Peng Chen,Pei-Ning Wang

Frontiers in aging neuroscience 13:657794 PubMed34122041

2021

The Role of Plasma Neurofilament Light Protein for Assessing Cognitive Impairment in Patients With End-Stage Renal Disease.

Applications

Unspecified application

Species

Unspecified reactive species

Yi-Chou Hou,Chuen-Lin Huang,Chien-Lin Lu,Cai-Mei Zheng,Yuh-Feng Lin,Kuo-Cheng Lu,Ya-Lin Chung,Ruei-Ming Chen

ACS chemical neuroscience 12:1376-1383 PubMed33825443

2021

Synergistic Association between Plasma Aβ and p-tau in Alzheimer's Disease but Not in Parkinson's Disease or Frontotemporal Dementia.

Applications

Unspecified application

Species

Unspecified reactive species

Ming-Jang Chiu,Shieh-Yueh Yang,Ta-Fu Chen,Chin-Hsien Lin,Fu-Chi Yang,Wen-Ping Chen,Henrik Zetterberg,Kaj Blennow

European journal of neurology 28:1479-1489 PubMed33370497

2021

Head-to-head comparison of amplified plasmonic exosome Aβ42 platform and single-molecule array immunoassay in a memory clinic cohort.

Applications

Unspecified application

Species

Unspecified reactive species

Tomotaka Tanaka,Joyce Chong Ruifen,Ying-Hwey Nai,Chin Hong Tan,Carine Z J Lim,Yan Zhang,Mary C Stephenson,Saima Hilal,Francis N Saridin,Bibek Gyanwali,Steven Villaraza,Edward G Robins,Masafumi Ihara,Michael Schöll,Henrik Zetterberg,Kaj Blennow,Nicholas J Ashton,Huilin Shao,Anthonin Reilhac,Christopher Chen

International journal of molecular sciences 22: PubMed33383667

2020

New Evidence for P-gp-Mediated Export of Amyloid-β PEPTIDES in Molecular, Blood-Brain Barrier and Neuronal Models.

Applications

Unspecified application

Species

Unspecified reactive species

Amanda B Chai,Anika M S Hartz,Xuexin Gao,Alryel Yang,Richard Callaghan,Ingrid C Gelissen

Alzheimer's research & therapy 11:111 PubMed31881963

2019

Plasma amyloid assay as a pre-screening tool for amyloid positron emission tomography imaging in early stage Alzheimer's disease.

Applications

Unspecified application

Species

Unspecified reactive species

Szu-Ying Lin,Kun-Ju Lin,Po-Chen Lin,Chin-Chang Huang,Chiung-Chih Chang,Yi-Chung Lee,Ing-Tsung Hsiao,Tzu-Chen Yen,Wen-Sheng Huang,Bang-Hung Yang,Pei-Ning Wang
View all publications

Product promise

We are committed to supporting your work with high-quality reagents, and we're here for you every step of the way. In the unlikely event that one of our products does not perform as expected, you're protected by our Product Promise.
For full details, please see our Terms & Conditions

Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.

For licensing inquiries, please contact partnerships@abcam.com